Top Markets
#1 Official Trump Official Trump +51.60%
#2 Movement Movement +32.33%
#3 Mubarak Mubarak +26.27%
#4 Pearl Pearl +24.49%
#5 Zama Zama +24.44%
#6 Melania Meme Melania Meme +22.38%
#7 EXOD EXOD +18.93%
#8 Wrapped POL Wrapped POL +18.74%
#9 POL (ex-MATIC) POL (ex-MATIC) +18.66%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +16.92%
Coin of the day
Official Trump Official Trump
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
Classement en actions #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
Prix de l'action
$0.7426
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$69.05M
Changement (1 jour)
-2.17%
Changement (1 an)
-57.57%
Pays
US
Échange Citius Oncology, Inc. (CTOR)

Catégorie

Healthcare
Historique du prix de l'action pour Citius Oncology, Inc. (CTOR)
Prix de clôture le plus élevé : $0.77 le 2026-08-01

Prix de clôture le plus bas : $11.37 le 2024-07-01
Historique du prix de l'action de Citius Oncology, Inc. de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -4.49%
2025 2.60%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.26K 76.64%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $270.77 51.02%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $265.40 26.02%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $493.69 44.66%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $152.42 74.45%
US